BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16925971)

  • 21. [Pathological and clinical features of malignant thyroid tumors: classification, immunohistology, prognostic criteria].
    Schröder S
    Veroff Pathol; 1988; 130():1-159. PubMed ID: 3213226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Follicular variant of papillary thyroid carcinoma presenting as a toxic nodule by I-123 scintigraphy.
    Bommireddipalli S; Goel S; Gadiraju R; Paniz-MondolFi A; DePuey EG
    Clin Nucl Med; 2010 Oct; 35(10):770-5. PubMed ID: 20838284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors related to the survival of papillary and follicular thyroid carcinoma patients with distant metastases.
    Lin JD; Huang MJ; Juang JH; Chao TC; Huang BY; Chen KW; Chen JY; Li KL; Chen JF; Ho YS
    Thyroid; 1999 Dec; 9(12):1227-35. PubMed ID: 10646663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Encapsulated follicular variant of papillary thyroid carcinoma with bone metastases.
    Baloch ZW; LiVolsi VA
    Mod Pathol; 2000 Aug; 13(8):861-5. PubMed ID: 10955452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary Thyroid Carcinoma with Low-Risk Histology and Distant Metastases: Clinicopathologic and Molecular Characteristics.
    Xu B; Tuttle RM; Sabra MM; Ganly I; Ghossein R
    Thyroid; 2017 May; 27(5):632-640. PubMed ID: 28049366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current controversies in the management of pediatric patients with well-differentiated nonmedullary thyroid cancer: a review.
    Hung W; Sarlis NJ
    Thyroid; 2002 Aug; 12(8):683-702. PubMed ID: 12225637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are the morphology of papillary thyroid carcinoma and the tumour's behaviour correlated?
    Hefer T; Joachims HZ; Eitan A; Munichor M
    J Laryngol Otol; 1996 Jul; 110(7):704-5. PubMed ID: 8759556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors that complicate the study of follicular variant of papillary thyroid cancer.
    Zeiger MA
    Cancer J; 2006; 12(4):250-2. PubMed ID: 16925968
    [No Abstract]   [Full Text] [Related]  

  • 29. Importance of tumour size in papillary and follicular thyroid cancer.
    Passler C; Scheuba C; Asari R; Kaczirek K; Kaserer K; Niederle B
    Br J Surg; 2005 Feb; 92(2):184-9. PubMed ID: 15685703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The History of the Follicular Variant of Papillary Thyroid Carcinoma.
    Tallini G; Tuttle RM; Ghossein RA
    J Clin Endocrinol Metab; 2017 Jan; 102(1):15-22. PubMed ID: 27732333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation between BRAF mutation and the clinicopathological parameters in papillary thyroid carcinoma with particular reference to follicular variant.
    Smith RA; Salajegheh A; Weinstein S; Nassiri M; Lam AK
    Hum Pathol; 2011 Apr; 42(4):500-6. PubMed ID: 21167555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anaplastic Transformation in Mandibular Metastases of Follicular Variant of Papillary Thyroid Carcinoma: A Case Report and Review of the Literature.
    Ambelil M; Sultana S; Roy S; Gonzalez MM
    Ann Clin Lab Sci; 2016 Sep; 46(5):552-6. PubMed ID: 27650625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors for central neck lymph node metastases in follicular variant vs. classic papillary thyroid carcinoma.
    Raffaelli M; De Crea C; Sessa L; Fadda G; Lombardi CP; Bellantone R
    Endocrine; 2018 Oct; 62(1):64-70. PubMed ID: 29770933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Follicular variant of papillary thyroid carcinoma. A clinicopathologic study.
    Tielens ET; Sherman SI; Hruban RH; Ladenson PW
    Cancer; 1994 Jan; 73(2):424-31. PubMed ID: 8293410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
    Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Composite follicular variant of papillary carcinoma and mucoepidermoid carcinoma of the thyroid. Report of a case and review of the literature.
    Miranda RN; Myint MA; Gnepp DR
    Am J Surg Pathol; 1995 Oct; 19(10):1209-15. PubMed ID: 7573680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early recurrence of papillary and follicular thyroid carcinoma predicts a worse outcome.
    Lin JD; Hsueh C; Chao TC
    Thyroid; 2009 Oct; 19(10):1053-9. PubMed ID: 19772423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thyroid nodules with FNA cytology suspicious for follicular variant of papillary thyroid carcinoma: follow-up and management.
    Logani S; Gupta PK; LiVolsi VA; Mandel S; Baloch ZW
    Diagn Cytopathol; 2000 Dec; 23(6):380-5. PubMed ID: 11074641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
    Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
    Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New insight in the follow-up strategies of differentiated thyroid cancer.
    Pacini F; Castagna MG
    J Endocrinol Invest; 2012; 35(6 Suppl):36-9. PubMed ID: 23014072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.